Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection: Analysis of treatment efficacy and failure in patients receiving postoperative or primary chemoradiation

Strahlentherapie und Onkologie

Volumn 188, Issue 9, 2012, Pages 795-801

  Habermehl, D ^a   Lindel, K ^a   Rieken, S ^a   Haase, K ^a   Goeppert, B ^b   Buchler M W ^a   Schirmacher, P ^b   Welzel, T ^a   Debus, J ^a   Combs, S E ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Extrahepatic bile duct cancer; Gemcitabine; Hilar cholangiocarcinoma; Klatskin tumour; Neoplasm recurrence, local

Indexed keywords

FLUOROURACIL; GEMCITABINE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD TOXICITY; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHOLANGITIS; CLINICAL ARTICLE; DIARRHEA; DISEASE COURSE; DISTANT METASTASIS; EPIGASTRIC PAIN; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; FOLLOW UP; HUMAN; KLATSKIN TUMOR; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; NAUSEA; OVERALL SURVIVAL; PERITONEUM METASTASIS; POSTOPERATIVE PERIOD; PROGRESSION FREE SURVIVAL; RADIATION DOSE; THERAPY EFFECT;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS; CHEMORADIOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; FEMALE; GERMANY; HEPATECTOMY; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE CARE; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84866660720     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0099-y     Document Type: Article

References (32)

1. Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31-38
2. Aljiffry M, Walsh MJ, Molinari M (2009) Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 15:4240-4262
3. Figueras J, Llado L, Valls C et al (2000) Changing strategies in diagnosis and management of hilar cholangiocarcinoma. Liver Transpl 6:786-794
4. Kim S, Kim SW, Bang YJ et al (2002) Role of postoperative radiotherapy in the management of extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 54:414-419
5. Nelson JW, Ghafoori AP, Willett CG et al (2009) Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 73:148-153
6. Todoroki T, Ohara K, Kawamoto T et al (2000) Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 46:581-587
7. Gerhards MF, Gulik TM van, Gonzalez Gonzalez D et al (2003) Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma. World J Surg 27:173-179
8. Shinohara ET, Mitra N, Guo M et al (2009) Radiotherapy is associated with improved survival in adjuvant and palliative treatment of extrahepatic cholangiocarcinomas. Int J Radiat Oncol Biol Phys 74:1191-1198
9. Brunner TB, Schwab D, Meyer T et al (2004) Chemoradiation may prolong survival of patients with non-bulky unresectable extrahepatic biliary carcinoma. A retrospective analysis. Strahlenther Onkol 180:751-757
10. Deodato F, Clemente G, Mattiucci GC et al (2006) Chemoradiation and brachytherapy in biliary tract carcinoma: long-term results. Int J Radiat Oncol Biol Phys 64:483-488
11. Crane CH, Macdonald KO, Vauthey JN et al (2002) Limitations of conventional doses of chemoradiation for unresectable biliary cancer. Int J Radiat Oncol Biol Phys 53:969-974
12. Brunner TB, Eccles CL (2010) Radiotherapy and chemotherapy as therapeutic strategies in extrahepatic biliary duct carcinoma. Strahlenther Onkol 186:672-680
13. Maluta S, Schaffer M, Pioli F et al (2011) Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer: an open-label comparative cohort trial. Strahlenther Onkol 187:619-625
14. Fuller CD, Wang SJ, Choi M et al (2009) Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population-based analysis. Cancer 115:5175-5183
15. Grove MK, Hermann RE, Vogt DP et al (1991) Role of radiation after operative palliation in cancer of the proximal bile ducts. Am J Surg 161:454-458
16. Schiffman SC, Reuter NP, McMasters KM et al (2011) Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol
17. Hughes MA, Frassica DA, Yeo CJ et al (2007) Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct. Int J Radiat Oncol Biol Phys 68:178-182
18. Serafini FM, Sachs D, Bloomston M et al (2001) Location, not staging, of cholangiocarcinoma determines the role for adjuvant chemoradiation therapy. Am Surg 67:839-843 (discussion 843-834)
19. Kim K, Chie EK, Jang JY et al (2011) Adjuvant chemoradiotherapy after curative resection for extrahepatic bile duct cancer: a long-term single center experience. Am J Clin Oncol
20. Park JH, Choi EK, Ahn SD et al (2011) Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys 79:696-704
21. Witzigmann H, Berr F, Ringel U et al (2006) Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection. Ann Surg 244:230-239
22. Jarnagin WR, Fong Y, DeMatteo RP et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507-517, discussion 517-509
23. Kresl JJ, Schild SE, Henning GT et al (2002) Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52:167-175
24. Schoppmeyer K, Miethe S, Wiedmann M et al (2006) Radiochemotherapy followed by gemcitabine and capecitabine in extrahepatic bile duct cancer: a phase I/II trial. Am J Clin Oncol 29:576-582
25. Schleicher UM, Staatz G, Alzen G et al (2002) Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors. Strahlenther Onkol 178:682-687
26. Foo ML, Gunderson LL, Bender CE et al (1997) External radiation therapy and transcatheter iridium in the treatment of extrahepatic bile duct carcinoma. Int J Radiat Oncol Biol Phys 39:929-935
27. Kopek N, Holt MI, Hansen AT et al (2010) Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94:47-52
28. Momm F, Schubert E, Henne K et al (2010) Stereotactic fractionated radiotherapy for Klatskin tumours. Radiother Oncol 95:99-102
29. Eppinga W, Lagerwaard F, Verbakel W et al (2010) Volumetric modulated arc therapy for advanced pancreatic cancer. Strahlenther Onkol 186:382-387
30. Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187:284-291
31. Wolff D, Stieler F, Hermann B et al (2010) Clinical implementation of volumetric intensity-modulated arc therapy (VMAT) with ERGO++. Strahlenther Onkol 186:280-288
32. Zamboglou C, Messmer MB, Becker G et al (2012) Stereotactic radiotherapy in the liver hilum. Basis for future studies. Strahlenther Onkol 188:35-41